Global Immune Cell Therapy Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Immune Cell Therapy Drugs market size was valued at US$ 2402.6 million in 2023. With growing demand in downstream market, the Immune Cell Therapy Drugs is forecast to a readjusted size of US$ 18040 million by 2030 with a CAGR of 33.4% during review period.
The research report highlights the growth potential of the global Immune Cell Therapy Drugs market. Immune Cell Therapy Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune Cell Therapy Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune Cell Therapy Drugs market.
Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient's immune response against diseases like cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Immune Cell Therapy Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune Cell Therapy Drugs market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Immunomodulator), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune Cell Therapy Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune Cell Therapy Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune Cell Therapy Drugs industry. This include advancements in Immune Cell Therapy Drugs technology, Immune Cell Therapy Drugs new entrants, Immune Cell Therapy Drugs new investment, and other innovations that are shaping the future of Immune Cell Therapy Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune Cell Therapy Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Immune Cell Therapy Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune Cell Therapy Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune Cell Therapy Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune Cell Therapy Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune Cell Therapy Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune Cell Therapy Drugs market.
Market Segmentation:
Immune Cell Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Immune Cell Therapy Drugs market size was valued at US$ 2402.6 million in 2023. With growing demand in downstream market, the Immune Cell Therapy Drugs is forecast to a readjusted size of US$ 18040 million by 2030 with a CAGR of 33.4% during review period.
The research report highlights the growth potential of the global Immune Cell Therapy Drugs market. Immune Cell Therapy Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune Cell Therapy Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune Cell Therapy Drugs market.
Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient's immune response against diseases like cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Immune Cell Therapy Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune Cell Therapy Drugs market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Immunomodulator), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune Cell Therapy Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune Cell Therapy Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune Cell Therapy Drugs industry. This include advancements in Immune Cell Therapy Drugs technology, Immune Cell Therapy Drugs new entrants, Immune Cell Therapy Drugs new investment, and other innovations that are shaping the future of Immune Cell Therapy Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune Cell Therapy Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Immune Cell Therapy Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune Cell Therapy Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune Cell Therapy Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune Cell Therapy Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune Cell Therapy Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune Cell Therapy Drugs market.
Market Segmentation:
Immune Cell Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Monoclonal Antibodies
- Immunomodulator
- Other
- Stomach Cancer
- lung Cancer
- Colorectal Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aquila BioMedical
- BPS Bioscience
- Celentyx
- Crown Bioscience
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences
- Horizon Discovery Group
- ImmunXperts
- Molecular Imaging
- Promega Corporation,Personalis
- STC Biologics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Cell Therapy Drugs Market Size 2019-2030
2.1.2 Immune Cell Therapy Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immune Cell Therapy Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Immunomodulator
2.2.3 Other
2.3 Immune Cell Therapy Drugs Market Size by Type
2.3.1 Immune Cell Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Immune Cell Therapy Drugs Segment by Application
2.4.1 Stomach Cancer
2.4.2 lung Cancer
2.4.3 Colorectal Cancer
2.4.4 Esophageal Cancer
2.4.5 Pancreatic Cancer
2.4.6 Other
2.5 Immune Cell Therapy Drugs Market Size by Application
2.5.1 Immune Cell Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
3 IMMUNE CELL THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Immune Cell Therapy Drugs Market Size Market Share by Players
3.1.1 Global Immune Cell Therapy Drugs Revenue by Players (2019-2024)
3.1.2 Global Immune Cell Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immune Cell Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNE CELL THERAPY DRUGS BY REGIONS
4.1 Immune Cell Therapy Drugs Market Size by Regions (2019-2024)
4.2 Americas Immune Cell Therapy Drugs Market Size Growth (2019-2024)
4.3 APAC Immune Cell Therapy Drugs Market Size Growth (2019-2024)
4.4 Europe Immune Cell Therapy Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Immune Cell Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immune Cell Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Immune Cell Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Immune Cell Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Cell Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Immune Cell Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Immune Cell Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immune Cell Therapy Drugs by Country (2019-2024)
7.2 Europe Immune Cell Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Immune Cell Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Cell Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Immune Cell Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNE CELL THERAPY DRUGS MARKET FORECAST
10.1 Global Immune Cell Therapy Drugs Forecast by Regions (2025-2030)
10.1.1 Global Immune Cell Therapy Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Immune Cell Therapy Drugs Forecast
10.1.3 APAC Immune Cell Therapy Drugs Forecast
10.1.4 Europe Immune Cell Therapy Drugs Forecast
10.1.5 Middle East & Africa Immune Cell Therapy Drugs Forecast
10.2 Americas Immune Cell Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Immune Cell Therapy Drugs Market Forecast
10.2.2 Canada Immune Cell Therapy Drugs Market Forecast
10.2.3 Mexico Immune Cell Therapy Drugs Market Forecast
10.2.4 Brazil Immune Cell Therapy Drugs Market Forecast
10.3 APAC Immune Cell Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Immune Cell Therapy Drugs Market Forecast
10.3.2 Japan Immune Cell Therapy Drugs Market Forecast
10.3.3 Korea Immune Cell Therapy Drugs Market Forecast
10.3.4 Southeast Asia Immune Cell Therapy Drugs Market Forecast
10.3.5 India Immune Cell Therapy Drugs Market Forecast
10.3.6 Australia Immune Cell Therapy Drugs Market Forecast
10.4 Europe Immune Cell Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Immune Cell Therapy Drugs Market Forecast
10.4.2 France Immune Cell Therapy Drugs Market Forecast
10.4.3 UK Immune Cell Therapy Drugs Market Forecast
10.4.4 Italy Immune Cell Therapy Drugs Market Forecast
10.4.5 Russia Immune Cell Therapy Drugs Market Forecast
10.5 Middle East & Africa Immune Cell Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Immune Cell Therapy Drugs Market Forecast
10.5.2 South Africa Immune Cell Therapy Drugs Market Forecast
10.5.3 Israel Immune Cell Therapy Drugs Market Forecast
10.5.4 Turkey Immune Cell Therapy Drugs Market Forecast
10.5.5 GCC Countries Immune Cell Therapy Drugs Market Forecast
10.6 Global Immune Cell Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Immune Cell Therapy Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Information
11.1.2 Aquila BioMedical Immune Cell Therapy Drugs Product Offered
11.1.3 Aquila BioMedical Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aquila BioMedical Main Business Overview
11.1.5 Aquila BioMedical Latest Developments
11.2 BPS Bioscience
11.2.1 BPS Bioscience Company Information
11.2.2 BPS Bioscience Immune Cell Therapy Drugs Product Offered
11.2.3 BPS Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BPS Bioscience Main Business Overview
11.2.5 BPS Bioscience Latest Developments
11.3 Celentyx
11.3.1 Celentyx Company Information
11.3.2 Celentyx Immune Cell Therapy Drugs Product Offered
11.3.3 Celentyx Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Celentyx Main Business Overview
11.3.5 Celentyx Latest Developments
11.4 Crown Bioscience
11.4.1 Crown Bioscience Company Information
11.4.2 Crown Bioscience Immune Cell Therapy Drugs Product Offered
11.4.3 Crown Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Crown Bioscience Main Business Overview
11.4.5 Crown Bioscience Latest Developments
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Information
11.5.2 DiscoverX Corporation Immune Cell Therapy Drugs Product Offered
11.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 DiscoverX Corporation Main Business Overview
11.5.5 DiscoverX Corporation Latest Developments
11.6 Explicyte
11.6.1 Explicyte Company Information
11.6.2 Explicyte Immune Cell Therapy Drugs Product Offered
11.6.3 Explicyte Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Explicyte Main Business Overview
11.6.5 Explicyte Latest Developments
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Information
11.7.2 Genscript Biotech Corporation Immune Cell Therapy Drugs Product Offered
11.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genscript Biotech Corporation Main Business Overview
11.7.5 Genscript Biotech Corporation Latest Developments
11.8 HD Biosciences
11.8.1 HD Biosciences Company Information
11.8.2 HD Biosciences Immune Cell Therapy Drugs Product Offered
11.8.3 HD Biosciences Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 HD Biosciences Main Business Overview
11.8.5 HD Biosciences Latest Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Information
11.9.2 Horizon Discovery Group Immune Cell Therapy Drugs Product Offered
11.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Horizon Discovery Group Main Business Overview
11.9.5 Horizon Discovery Group Latest Developments
11.10 ImmunXperts
11.10.1 ImmunXperts Company Information
11.10.2 ImmunXperts Immune Cell Therapy Drugs Product Offered
11.10.3 ImmunXperts Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 ImmunXperts Main Business Overview
11.10.5 ImmunXperts Latest Developments
11.11 Molecular Imaging
11.11.1 Molecular Imaging Company Information
11.11.2 Molecular Imaging Immune Cell Therapy Drugs Product Offered
11.11.3 Molecular Imaging Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Molecular Imaging Main Business Overview
11.11.5 Molecular Imaging Latest Developments
11.12 Promega Corporation,Personalis
11.12.1 Promega Corporation,Personalis Company Information
11.12.2 Promega Corporation,Personalis Immune Cell Therapy Drugs Product Offered
11.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Promega Corporation,Personalis Main Business Overview
11.12.5 Promega Corporation,Personalis Latest Developments
11.13 STC Biologics
11.13.1 STC Biologics Company Information
11.13.2 STC Biologics Immune Cell Therapy Drugs Product Offered
11.13.3 STC Biologics Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 STC Biologics Main Business Overview
11.13.5 STC Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Cell Therapy Drugs Market Size 2019-2030
2.1.2 Immune Cell Therapy Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immune Cell Therapy Drugs Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Immunomodulator
2.2.3 Other
2.3 Immune Cell Therapy Drugs Market Size by Type
2.3.1 Immune Cell Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
2.4 Immune Cell Therapy Drugs Segment by Application
2.4.1 Stomach Cancer
2.4.2 lung Cancer
2.4.3 Colorectal Cancer
2.4.4 Esophageal Cancer
2.4.5 Pancreatic Cancer
2.4.6 Other
2.5 Immune Cell Therapy Drugs Market Size by Application
2.5.1 Immune Cell Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
3 IMMUNE CELL THERAPY DRUGS MARKET SIZE BY PLAYER
3.1 Immune Cell Therapy Drugs Market Size Market Share by Players
3.1.1 Global Immune Cell Therapy Drugs Revenue by Players (2019-2024)
3.1.2 Global Immune Cell Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immune Cell Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNE CELL THERAPY DRUGS BY REGIONS
4.1 Immune Cell Therapy Drugs Market Size by Regions (2019-2024)
4.2 Americas Immune Cell Therapy Drugs Market Size Growth (2019-2024)
4.3 APAC Immune Cell Therapy Drugs Market Size Growth (2019-2024)
4.4 Europe Immune Cell Therapy Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Immune Cell Therapy Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immune Cell Therapy Drugs Market Size by Country (2019-2024)
5.2 Americas Immune Cell Therapy Drugs Market Size by Type (2019-2024)
5.3 Americas Immune Cell Therapy Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Cell Therapy Drugs Market Size by Region (2019-2024)
6.2 APAC Immune Cell Therapy Drugs Market Size by Type (2019-2024)
6.3 APAC Immune Cell Therapy Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immune Cell Therapy Drugs by Country (2019-2024)
7.2 Europe Immune Cell Therapy Drugs Market Size by Type (2019-2024)
7.3 Europe Immune Cell Therapy Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Cell Therapy Drugs by Region (2019-2024)
8.2 Middle East & Africa Immune Cell Therapy Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNE CELL THERAPY DRUGS MARKET FORECAST
10.1 Global Immune Cell Therapy Drugs Forecast by Regions (2025-2030)
10.1.1 Global Immune Cell Therapy Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Immune Cell Therapy Drugs Forecast
10.1.3 APAC Immune Cell Therapy Drugs Forecast
10.1.4 Europe Immune Cell Therapy Drugs Forecast
10.1.5 Middle East & Africa Immune Cell Therapy Drugs Forecast
10.2 Americas Immune Cell Therapy Drugs Forecast by Country (2025-2030)
10.2.1 United States Immune Cell Therapy Drugs Market Forecast
10.2.2 Canada Immune Cell Therapy Drugs Market Forecast
10.2.3 Mexico Immune Cell Therapy Drugs Market Forecast
10.2.4 Brazil Immune Cell Therapy Drugs Market Forecast
10.3 APAC Immune Cell Therapy Drugs Forecast by Region (2025-2030)
10.3.1 China Immune Cell Therapy Drugs Market Forecast
10.3.2 Japan Immune Cell Therapy Drugs Market Forecast
10.3.3 Korea Immune Cell Therapy Drugs Market Forecast
10.3.4 Southeast Asia Immune Cell Therapy Drugs Market Forecast
10.3.5 India Immune Cell Therapy Drugs Market Forecast
10.3.6 Australia Immune Cell Therapy Drugs Market Forecast
10.4 Europe Immune Cell Therapy Drugs Forecast by Country (2025-2030)
10.4.1 Germany Immune Cell Therapy Drugs Market Forecast
10.4.2 France Immune Cell Therapy Drugs Market Forecast
10.4.3 UK Immune Cell Therapy Drugs Market Forecast
10.4.4 Italy Immune Cell Therapy Drugs Market Forecast
10.4.5 Russia Immune Cell Therapy Drugs Market Forecast
10.5 Middle East & Africa Immune Cell Therapy Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Immune Cell Therapy Drugs Market Forecast
10.5.2 South Africa Immune Cell Therapy Drugs Market Forecast
10.5.3 Israel Immune Cell Therapy Drugs Market Forecast
10.5.4 Turkey Immune Cell Therapy Drugs Market Forecast
10.5.5 GCC Countries Immune Cell Therapy Drugs Market Forecast
10.6 Global Immune Cell Therapy Drugs Forecast by Type (2025-2030)
10.7 Global Immune Cell Therapy Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Information
11.1.2 Aquila BioMedical Immune Cell Therapy Drugs Product Offered
11.1.3 Aquila BioMedical Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aquila BioMedical Main Business Overview
11.1.5 Aquila BioMedical Latest Developments
11.2 BPS Bioscience
11.2.1 BPS Bioscience Company Information
11.2.2 BPS Bioscience Immune Cell Therapy Drugs Product Offered
11.2.3 BPS Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BPS Bioscience Main Business Overview
11.2.5 BPS Bioscience Latest Developments
11.3 Celentyx
11.3.1 Celentyx Company Information
11.3.2 Celentyx Immune Cell Therapy Drugs Product Offered
11.3.3 Celentyx Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Celentyx Main Business Overview
11.3.5 Celentyx Latest Developments
11.4 Crown Bioscience
11.4.1 Crown Bioscience Company Information
11.4.2 Crown Bioscience Immune Cell Therapy Drugs Product Offered
11.4.3 Crown Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Crown Bioscience Main Business Overview
11.4.5 Crown Bioscience Latest Developments
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Information
11.5.2 DiscoverX Corporation Immune Cell Therapy Drugs Product Offered
11.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 DiscoverX Corporation Main Business Overview
11.5.5 DiscoverX Corporation Latest Developments
11.6 Explicyte
11.6.1 Explicyte Company Information
11.6.2 Explicyte Immune Cell Therapy Drugs Product Offered
11.6.3 Explicyte Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Explicyte Main Business Overview
11.6.5 Explicyte Latest Developments
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Information
11.7.2 Genscript Biotech Corporation Immune Cell Therapy Drugs Product Offered
11.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genscript Biotech Corporation Main Business Overview
11.7.5 Genscript Biotech Corporation Latest Developments
11.8 HD Biosciences
11.8.1 HD Biosciences Company Information
11.8.2 HD Biosciences Immune Cell Therapy Drugs Product Offered
11.8.3 HD Biosciences Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 HD Biosciences Main Business Overview
11.8.5 HD Biosciences Latest Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Information
11.9.2 Horizon Discovery Group Immune Cell Therapy Drugs Product Offered
11.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Horizon Discovery Group Main Business Overview
11.9.5 Horizon Discovery Group Latest Developments
11.10 ImmunXperts
11.10.1 ImmunXperts Company Information
11.10.2 ImmunXperts Immune Cell Therapy Drugs Product Offered
11.10.3 ImmunXperts Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 ImmunXperts Main Business Overview
11.10.5 ImmunXperts Latest Developments
11.11 Molecular Imaging
11.11.1 Molecular Imaging Company Information
11.11.2 Molecular Imaging Immune Cell Therapy Drugs Product Offered
11.11.3 Molecular Imaging Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Molecular Imaging Main Business Overview
11.11.5 Molecular Imaging Latest Developments
11.12 Promega Corporation,Personalis
11.12.1 Promega Corporation,Personalis Company Information
11.12.2 Promega Corporation,Personalis Immune Cell Therapy Drugs Product Offered
11.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Promega Corporation,Personalis Main Business Overview
11.12.5 Promega Corporation,Personalis Latest Developments
11.13 STC Biologics
11.13.1 STC Biologics Company Information
11.13.2 STC Biologics Immune Cell Therapy Drugs Product Offered
11.13.3 STC Biologics Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 STC Biologics Main Business Overview
11.13.5 STC Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immune Cell Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Immunomodulator
Table 4. Major Players of Other
Table 5. Immune Cell Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 8. Immune Cell Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global Immune Cell Therapy Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Immune Cell Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 13. Immune Cell Therapy Drugs Key Players Head office and Products Offered
Table 14. Immune Cell Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immune Cell Therapy Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Immune Cell Therapy Drugs Market Size Market Share by Regions (2019-2024)
Table 19. Global Immune Cell Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Immune Cell Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Immune Cell Therapy Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Immune Cell Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC Immune Cell Therapy Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Immune Cell Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 31. APAC Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 33. Europe Immune Cell Therapy Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Immune Cell Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 37. Europe Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Immune Cell Therapy Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Immune Cell Therapy Drugs
Table 46. Key Market Challenges & Risks of Immune Cell Therapy Drugs
Table 47. Key Industry Trends of Immune Cell Therapy Drugs
Table 48. Global Immune Cell Therapy Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Immune Cell Therapy Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Immune Cell Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Immune Cell Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Aquila BioMedical Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 53. Aquila BioMedical Immune Cell Therapy Drugs Product Offered
Table 54. Aquila BioMedical Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Aquila BioMedical Main Business
Table 56. Aquila BioMedical Latest Developments
Table 57. BPS Bioscience Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 58. BPS Bioscience Immune Cell Therapy Drugs Product Offered
Table 59. BPS Bioscience Main Business
Table 60. BPS Bioscience Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. BPS Bioscience Latest Developments
Table 62. Celentyx Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 63. Celentyx Immune Cell Therapy Drugs Product Offered
Table 64. Celentyx Main Business
Table 65. Celentyx Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Celentyx Latest Developments
Table 67. Crown Bioscience Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 68. Crown Bioscience Immune Cell Therapy Drugs Product Offered
Table 69. Crown Bioscience Main Business
Table 70. Crown Bioscience Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Crown Bioscience Latest Developments
Table 72. DiscoverX Corporation Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 73. DiscoverX Corporation Immune Cell Therapy Drugs Product Offered
Table 74. DiscoverX Corporation Main Business
Table 75. DiscoverX Corporation Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. DiscoverX Corporation Latest Developments
Table 77. Explicyte Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 78. Explicyte Immune Cell Therapy Drugs Product Offered
Table 79. Explicyte Main Business
Table 80. Explicyte Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Explicyte Latest Developments
Table 82. Genscript Biotech Corporation Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 83. Genscript Biotech Corporation Immune Cell Therapy Drugs Product Offered
Table 84. Genscript Biotech Corporation Main Business
Table 85. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Genscript Biotech Corporation Latest Developments
Table 87. HD Biosciences Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 88. HD Biosciences Immune Cell Therapy Drugs Product Offered
Table 89. HD Biosciences Main Business
Table 90. HD Biosciences Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. HD Biosciences Latest Developments
Table 92. Horizon Discovery Group Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 93. Horizon Discovery Group Immune Cell Therapy Drugs Product Offered
Table 94. Horizon Discovery Group Main Business
Table 95. Horizon Discovery Group Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Horizon Discovery Group Latest Developments
Table 97. ImmunXperts Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 98. ImmunXperts Immune Cell Therapy Drugs Product Offered
Table 99. ImmunXperts Main Business
Table 100. ImmunXperts Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. ImmunXperts Latest Developments
Table 102. Molecular Imaging Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 103. Molecular Imaging Immune Cell Therapy Drugs Product Offered
Table 104. Molecular Imaging Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Molecular Imaging Main Business
Table 106. Molecular Imaging Latest Developments
Table 107. Promega Corporation,Personalis Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 108. Promega Corporation,Personalis Immune Cell Therapy Drugs Product Offered
Table 109. Promega Corporation,Personalis Main Business
Table 110. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Promega Corporation,Personalis Latest Developments
Table 112. STC Biologics Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 113. STC Biologics Immune Cell Therapy Drugs Product Offered
Table 114. STC Biologics Main Business
Table 115. STC Biologics Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. STC Biologics Latest Developments
Table 1. Immune Cell Therapy Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Immunomodulator
Table 4. Major Players of Other
Table 5. Immune Cell Therapy Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 8. Immune Cell Therapy Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global Immune Cell Therapy Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Immune Cell Therapy Drugs Revenue Market Share by Player (2019-2024)
Table 13. Immune Cell Therapy Drugs Key Players Head office and Products Offered
Table 14. Immune Cell Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immune Cell Therapy Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Immune Cell Therapy Drugs Market Size Market Share by Regions (2019-2024)
Table 19. Global Immune Cell Therapy Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Immune Cell Therapy Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Immune Cell Therapy Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Immune Cell Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 25. Americas Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC Immune Cell Therapy Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Immune Cell Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 31. APAC Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 33. Europe Immune Cell Therapy Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Immune Cell Therapy Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 37. Europe Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Immune Cell Therapy Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Immune Cell Therapy Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Immune Cell Therapy Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Immune Cell Therapy Drugs
Table 46. Key Market Challenges & Risks of Immune Cell Therapy Drugs
Table 47. Key Industry Trends of Immune Cell Therapy Drugs
Table 48. Global Immune Cell Therapy Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Immune Cell Therapy Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Immune Cell Therapy Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Immune Cell Therapy Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Aquila BioMedical Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 53. Aquila BioMedical Immune Cell Therapy Drugs Product Offered
Table 54. Aquila BioMedical Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Aquila BioMedical Main Business
Table 56. Aquila BioMedical Latest Developments
Table 57. BPS Bioscience Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 58. BPS Bioscience Immune Cell Therapy Drugs Product Offered
Table 59. BPS Bioscience Main Business
Table 60. BPS Bioscience Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. BPS Bioscience Latest Developments
Table 62. Celentyx Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 63. Celentyx Immune Cell Therapy Drugs Product Offered
Table 64. Celentyx Main Business
Table 65. Celentyx Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Celentyx Latest Developments
Table 67. Crown Bioscience Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 68. Crown Bioscience Immune Cell Therapy Drugs Product Offered
Table 69. Crown Bioscience Main Business
Table 70. Crown Bioscience Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Crown Bioscience Latest Developments
Table 72. DiscoverX Corporation Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 73. DiscoverX Corporation Immune Cell Therapy Drugs Product Offered
Table 74. DiscoverX Corporation Main Business
Table 75. DiscoverX Corporation Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. DiscoverX Corporation Latest Developments
Table 77. Explicyte Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 78. Explicyte Immune Cell Therapy Drugs Product Offered
Table 79. Explicyte Main Business
Table 80. Explicyte Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Explicyte Latest Developments
Table 82. Genscript Biotech Corporation Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 83. Genscript Biotech Corporation Immune Cell Therapy Drugs Product Offered
Table 84. Genscript Biotech Corporation Main Business
Table 85. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Genscript Biotech Corporation Latest Developments
Table 87. HD Biosciences Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 88. HD Biosciences Immune Cell Therapy Drugs Product Offered
Table 89. HD Biosciences Main Business
Table 90. HD Biosciences Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. HD Biosciences Latest Developments
Table 92. Horizon Discovery Group Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 93. Horizon Discovery Group Immune Cell Therapy Drugs Product Offered
Table 94. Horizon Discovery Group Main Business
Table 95. Horizon Discovery Group Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Horizon Discovery Group Latest Developments
Table 97. ImmunXperts Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 98. ImmunXperts Immune Cell Therapy Drugs Product Offered
Table 99. ImmunXperts Main Business
Table 100. ImmunXperts Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. ImmunXperts Latest Developments
Table 102. Molecular Imaging Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 103. Molecular Imaging Immune Cell Therapy Drugs Product Offered
Table 104. Molecular Imaging Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Molecular Imaging Main Business
Table 106. Molecular Imaging Latest Developments
Table 107. Promega Corporation,Personalis Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 108. Promega Corporation,Personalis Immune Cell Therapy Drugs Product Offered
Table 109. Promega Corporation,Personalis Main Business
Table 110. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Promega Corporation,Personalis Latest Developments
Table 112. STC Biologics Details, Company Type, Immune Cell Therapy Drugs Area Served and Its Competitors
Table 113. STC Biologics Immune Cell Therapy Drugs Product Offered
Table 114. STC Biologics Main Business
Table 115. STC Biologics Immune Cell Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. STC Biologics Latest Developments
LIST OF FIGURES
Figure 1. Immune Cell Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immune Cell Therapy Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immune Cell Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immune Cell Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Immune Cell Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immune Cell Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Immune Cell Therapy Drugs in Stomach Cancer
Figure 11. Global Immune Cell Therapy Drugs Market: Stomach Cancer (2019-2024) & ($ Millions)
Figure 12. Immune Cell Therapy Drugs in lung Cancer
Figure 13. Global Immune Cell Therapy Drugs Market: lung Cancer (2019-2024) & ($ Millions)
Figure 14. Immune Cell Therapy Drugs in Colorectal Cancer
Figure 15. Global Immune Cell Therapy Drugs Market: Colorectal Cancer (2019-2024) & ($ Millions)
Figure 16. Immune Cell Therapy Drugs in Esophageal Cancer
Figure 17. Global Immune Cell Therapy Drugs Market: Esophageal Cancer (2019-2024) & ($ Millions)
Figure 18. Immune Cell Therapy Drugs in Pancreatic Cancer
Figure 19. Global Immune Cell Therapy Drugs Market: Pancreatic Cancer (2019-2024) & ($ Millions)
Figure 20. Immune Cell Therapy Drugs in Other
Figure 21. Global Immune Cell Therapy Drugs Market: Other (2019-2024) & ($ Millions)
Figure 22. Global Immune Cell Therapy Drugs Market Size Market Share by Application in 2023
Figure 23. Global Immune Cell Therapy Drugs Revenue Market Share by Player in 2023
Figure 24. Global Immune Cell Therapy Drugs Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 26. APAC Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 27. Europe Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 29. Americas Immune Cell Therapy Drugs Value Market Share by Country in 2023
Figure 30. United States Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Immune Cell Therapy Drugs Market Size Market Share by Region in 2023
Figure 35. APAC Immune Cell Therapy Drugs Market Size Market Share by Type in 2023
Figure 36. APAC Immune Cell Therapy Drugs Market Size Market Share by Application in 2023
Figure 37. China Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Immune Cell Therapy Drugs Market Size Market Share by Country in 2023
Figure 44. Europe Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Europe Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Germany Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 60. APAC Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Europe Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 63. United States Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Canada Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 67. China Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Japan Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Korea Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 71. India Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Australia Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Germany Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 74. France Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 75. UK Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Italy Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Russia Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Spain Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 81. Israel Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 84. Global Immune Cell Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Immune Cell Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Immune Cell Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immune Cell Therapy Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immune Cell Therapy Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immune Cell Therapy Drugs Sales Market Share by Country/Region (2023)
Figure 8. Immune Cell Therapy Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immune Cell Therapy Drugs Market Size Market Share by Type in 2023
Figure 10. Immune Cell Therapy Drugs in Stomach Cancer
Figure 11. Global Immune Cell Therapy Drugs Market: Stomach Cancer (2019-2024) & ($ Millions)
Figure 12. Immune Cell Therapy Drugs in lung Cancer
Figure 13. Global Immune Cell Therapy Drugs Market: lung Cancer (2019-2024) & ($ Millions)
Figure 14. Immune Cell Therapy Drugs in Colorectal Cancer
Figure 15. Global Immune Cell Therapy Drugs Market: Colorectal Cancer (2019-2024) & ($ Millions)
Figure 16. Immune Cell Therapy Drugs in Esophageal Cancer
Figure 17. Global Immune Cell Therapy Drugs Market: Esophageal Cancer (2019-2024) & ($ Millions)
Figure 18. Immune Cell Therapy Drugs in Pancreatic Cancer
Figure 19. Global Immune Cell Therapy Drugs Market: Pancreatic Cancer (2019-2024) & ($ Millions)
Figure 20. Immune Cell Therapy Drugs in Other
Figure 21. Global Immune Cell Therapy Drugs Market: Other (2019-2024) & ($ Millions)
Figure 22. Global Immune Cell Therapy Drugs Market Size Market Share by Application in 2023
Figure 23. Global Immune Cell Therapy Drugs Revenue Market Share by Player in 2023
Figure 24. Global Immune Cell Therapy Drugs Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 26. APAC Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 27. Europe Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Immune Cell Therapy Drugs Market Size 2019-2024 ($ Millions)
Figure 29. Americas Immune Cell Therapy Drugs Value Market Share by Country in 2023
Figure 30. United States Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Immune Cell Therapy Drugs Market Size Market Share by Region in 2023
Figure 35. APAC Immune Cell Therapy Drugs Market Size Market Share by Type in 2023
Figure 36. APAC Immune Cell Therapy Drugs Market Size Market Share by Application in 2023
Figure 37. China Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Immune Cell Therapy Drugs Market Size Market Share by Country in 2023
Figure 44. Europe Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Europe Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Germany Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Immune Cell Therapy Drugs Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Immune Cell Therapy Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 60. APAC Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Europe Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 63. United States Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Canada Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 67. China Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Japan Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Korea Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 71. India Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Australia Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Germany Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 74. France Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 75. UK Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Italy Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Russia Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Spain Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 81. Israel Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Immune Cell Therapy Drugs Market Size 2025-2030 ($ Millions)
Figure 84. Global Immune Cell Therapy Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Immune Cell Therapy Drugs Market Size Market Share Forecast by Application (2025-2030)
